Danaher Corp. stock at EUR 196.80, market value USD 154.7 billion

Published on 10/09/2026 at 20:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher Corp. stock costs EUR 196.80 on October 9, 2026. Market value is USD 154.7 billion, P/E is 39.1, and Q2 revenue was USD 6.26 billion.

Key points in brief

Danaher Corp. stock was EUR 196.80 at Lang & Schwarz on October 9, 2026 at 8:01 p.m. CEST.
Market capitalization was USD 154.7 billion and the P/E ratio was 39.1.
Second-quarter 2026 revenue reached USD 6.26 billion, while October 21 is the scheduled earnings date.

Pop-Art-Comic einer begeisterten Wissenschaftlerin mit leuchtendem Reagenzglas im Retro-Halftone-Stil — Danaher Corp. Life-Sciences-Entdeckung US2358511028 als bunter Pop-Art-Comic mit Forscherin und leuchtendem Reagenzglas, Illustration mit AI erstellt.

Danaher Corp. stock was trading at EUR 196.80 at Lang & Schwarz on October 9, 2026 at 8:01 p.m. CEST, with a bid of EUR 196.70 and an ask of EUR 196.90. The price gives the market report a clear valuation angle because Danaher's market capitalization was USD 154.7 billion and its P/E ratio was 39.11 on October 9, 2026.

Price sits below yearly high

The primary-market quote was USD 220.09 on the New York Stock Exchange at 6:02 p.m. UTC on October 9, 2026. The same quotation showed a 52-week range of USD 160.93 to USD 242.80, placing the primary-market price 9.36 percent below the upper end of that range.

Trading volume stood at 1,729,053 shares against an average volume of 4,743,425 shares on October 9, 2026. Danaher therefore traded at 36.44 percent of its average volume in the quoted session, a subdued activity level alongside the EUR 196.80 German-market indication.

Quarterly revenue provides a base

According to MarketBeat, Danaher reported USD 6.26 billion of revenue in the second quarter of 2026, up 5.50 percent from the year-earlier quarter. The same report said earnings per share reached USD 1.94 against a consensus estimate of USD 1.85, a USD 0.09 beat.

Danaher's own quarterly data also put second-quarter 2026 net income at USD 870.0 million and diluted earnings per share at USD 1.23 on a GAAP basis. The difference between the GAAP figure and the adjusted figure cited by MarketBeat matters because investors are comparing different earnings measures.

Comparison with peers

Danaher Corp.: P/E 39.1, market capitalization USD 154.7 billion

Thermo Fisher Scientific (NYSE, USD): P/E 35.5, market capitalization USD 244.1 billion

Abbott Laboratories (NYSE, USD): P/E 31.9, market capitalization USD 171.5 billion

Analyst target remains higher

Barclays raised its Danaher target from USD 230.00 to USD 255.00 while maintaining an Overweight rating, as MarketBeat reported on October 7, 2026. The USD 255.00 target was 15.86 percent above the USD 220.09 primary-market quote.

RBC Capital also raised its target from USD 215.00 to USD 250.00 on October 5, 2026, according to Markets Insider. That target was 11.77 percent above the primary-market quote.

Next earnings date is October 21

Danaher is scheduled to report its next earnings on October 21, 2026, according to Investing.com. That date gives the second-quarter revenue growth and the analyst target revisions a clear near-term reference point.

The further course of trading is shown by the continuously updated real-time quote of Danaher Corp. stock.